NGM Biopharmaceuticals Inc (NGM)
NASDAQ:NGM
Holding NGM?
Track your performance easily

NGM Biopharmaceuticals (NGM) Cash flow

330 Followers

NGM Biopharmaceuticals Cash Flow

NGM's free cash flow for Q3 2023 was $-27.49M. For the 2023 fiscal year, NGM's free cash flow was decreased by $-71.38M and operating cash flow was $-27.20M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -139.66M$ -144.44M$ -73.23M$ -83.50M$ -41.17M$ -7.60M
Investing Cash Flow
$ 88.78M$ 14.32M$ -71.65M$ -51.00M$ 48.72M$ 38.73M
Financing Cash Flow
$ 2.39M$ 54.23M$ 149.66M$ 35.54M$ 180.75M$ 198.00K
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 263.07M$ 77.41M$ 153.31M$ 148.52M$ 247.47M$ 59.17M
Income Tax Paid Supplemental Data
----$ 0.00$ 1.00K
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
--$ 134.58M$ 0.00$ 175.91M$ 0.00
Issuance Of Debt
------
Repayment Of Debt
------
Free Cash Flow
$ -141.16M$ -146.30M$ -74.91M$ -85.38M$ -44.66M$ -13.44M
Domestic Sales
------
Foreign Sales
------
Currency in USD

NGM Biopharmaceuticals Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis